enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 8-K
Filing Date: 07 May 2026Report Date: 05 May 2026
Accepted: 07 May 2026 05:11 a.m.
Accession Number: 0001193125-26-210316
File Number: 001-41854
Film Number: 26950832
Items: 5.02,7.01,8.01,9.01
Documents
Primary Document: 8-K
Accepted: 07 May 2026 05:11 a.m.
0001193125-26-210316-index-headers.html
Last Modified: 07 May 2026 05:11 a.m.
0001193125-26-210316-index.html
Last Modified: 07 May 2026 05:11 a.m.
0001193125-26-210316.txt
Last Modified: 07 May 2026 05:11 a.m.
0001193125-26-210316-xbrl.zip
Last Modified: 07 May 2026 05:11 a.m.
d335486d8k_htm.xml
Last Modified: 07 May 2026 05:11 a.m.
d335486dex991.htm
Last Modified: 07 May 2026 05:11 a.m.
d335486dex992.htm
Last Modified: 07 May 2026 05:11 a.m.
engn-20260505.xsd
Last Modified: 07 May 2026 05:11 a.m.
engn-20260505_def.xml
Last Modified: 07 May 2026 05:11 a.m.
engn-20260505_lab.xml
Last Modified: 07 May 2026 05:11 a.m.
engn-20260505_pre.xml
Last Modified: 07 May 2026 05:11 a.m.
FilingSummary.xml
Last Modified: 07 May 2026 05:11 a.m.
g335486dsp06.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s10g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s11g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s12g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s13g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s14g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s15g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s16g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s17g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s18g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s19g1.jpg
Last Modified: 07 May 2026 05:11 a.m.
g335486ex99_2s1g1.jpg
Last Modified: 07 May 2026 05:11 a.m.